Interrogating basal ganglia reinforcement with deep brain stimulation in Parkinson’s disease.
ReinforceBG aims to explore dopamine's role in Parkinson's disease through advanced neuromodulation techniques to enhance understanding and develop innovative treatments for motor and cognitive symptoms.
Projectdetails
Introduction
Dopamine and the basal ganglia have been conserved over more than 500 million years of evolution. They are fundamental to animal and human behaviour. Parkinson's disease (PD) is associated with loss of dopaminergic innervation to the basal ganglia. Over 6 million people suffer from the debilitating symptoms of PD that span disturbance of emotion, cognition, and movement.
Need for Understanding
There is a pressing need to understand the pathogenesis of these symptoms, but an integrated account of dopamine and basal ganglia function is lacking. This constitutes a significant roadblock to scientific and therapeutic advances.
Novel Hypothesis
To overcome this roadblock, ReinforceBG poses the novel unconventional hypothesis that loss of dopamine in PD does not impair movement per se but leads to chronic negative reinforcement of neural population dynamics. Conversely, in the healthy state, transient dopamine signals may stabilize cortex-basal ganglia activity to facilitate reentry and refinement of cortical output.
Research Methodology
To address this hypothesis, ReinforceBG will combine invasive electrocorticography and local field potential recordings with closed-loop deep brain stimulation in PD patients.
Aims of the Project
- Aim 1: Investigate how basal ganglia pathways coordinate neuromuscular adaptation.
- Aim 2: Shed light on basal ganglia reinforcement in multiple behavioural domains, including movement, gait, speech, and spatial navigation in virtual reality.
- Aim 3: Develop a neuroprosthetic brain-computer interface that aims to modulate basal ganglia reinforcement.
Innovative Approach
ReinforceBG deviates from outdated models on pro- vs. antikinetic Go and NoGo pathways and promises a holistic-reinforcement centred view of basal ganglia function. It will leverage the unprecedented spatiotemporal precision of neuromodulation for the development of an innovative brain circuit intervention that modulates neural reinforcement in real time.
Future Implications
This opens new horizons for the interdisciplinary treatment of brain disorders affecting the dopaminergic system.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.580 |
Totale projectbegroting | € 1.499.580 |
Tijdlijn
Startdatum | 1-3-2023 |
Einddatum | 29-2-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Atlas of the Human Deep Brain Nuclei, Connections, and VasculatureThe project aims to create an atlas of human deep brain nuclei and vasculature to enhance deep-brain stimulation outcomes and minimize side effects in movement and neuropsychiatric disorders. | ERC Proof of... | € 150.000 | 2023 | Details |
Desynchronizing weak cortical fields during deep brain stimulationDECODE aims to enhance deep brain stimulation for Parkinson's by investigating weak electric fields' role in desynchronizing neural activity to improve motor control and reduce side effects. | ERC Starting... | € 1.498.914 | 2024 | Details |
Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopyThis project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients. | ERC Starting... | € 1.498.729 | 2024 | Details |
Neuromodulatory control of brain network dynamicsThis project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience. | ERC Consolid... | € 1.999.438 | 2025 | Details |
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental HealthThis project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders. | ERC Consolid... | € 1.999.875 | 2025 | Details |
Atlas of the Human Deep Brain Nuclei, Connections, and Vasculature
The project aims to create an atlas of human deep brain nuclei and vasculature to enhance deep-brain stimulation outcomes and minimize side effects in movement and neuropsychiatric disorders.
Desynchronizing weak cortical fields during deep brain stimulation
DECODE aims to enhance deep brain stimulation for Parkinson's by investigating weak electric fields' role in desynchronizing neural activity to improve motor control and reduce side effects.
Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopy
This project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients.
Neuromodulatory control of brain network dynamics
This project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience.
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health
This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative DiseaseThe project aims to develop a novel human brain-organoid model, called connectoids, to replace animal testing for Parkinson's disease, enhancing therapy monitoring and reducing societal burdens. | EIC Pathfinder | € 2.992.203 | 2022 | Details |
Revolutionary therapeutic treatment for stopping progression of Parkinson's diseaseHerantis is developing HER-096, a novel pharmaceutical aimed at modifying Parkinson's disease pathology to alleviate symptoms and reduce the societal burden of the condition. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Adpative DBSAlphaDBS enhances DBS treatment for Parkinson's by using adaptive stimulation based on local field potentials to optimize energy delivery in real-time. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learningCROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy. | EIC Pathfinder | € 4.034.074 | 2022 | Details |
Mapping the brain-spinal cord interaction towards understanding and treatment of movement disordersMove2Treat aims to develop a novel bi-directional brain-spinal cord interface to enhance understanding and treatment of movement disorders through advanced neuronal circuit mapping. | EIC Pathfinder | € 2.996.048 | 2024 | Details |
Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease
The project aims to develop a novel human brain-organoid model, called connectoids, to replace animal testing for Parkinson's disease, enhancing therapy monitoring and reducing societal burdens.
Revolutionary therapeutic treatment for stopping progression of Parkinson's disease
Herantis is developing HER-096, a novel pharmaceutical aimed at modifying Parkinson's disease pathology to alleviate symptoms and reduce the societal burden of the condition.
Adpative DBS
AlphaDBS enhances DBS treatment for Parkinson's by using adaptive stimulation based on local field potentials to optimize energy delivery in real-time.
Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning
CROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy.
Mapping the brain-spinal cord interaction towards understanding and treatment of movement disorders
Move2Treat aims to develop a novel bi-directional brain-spinal cord interface to enhance understanding and treatment of movement disorders through advanced neuronal circuit mapping.